| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $147.40B | -13.3% |
| Cost of Revenue | $128.09B | -14.6% |
| R&D Expense | $27.0M | -35.7% |
| SG&A Expense | $2.52B | +16.5% |
| Interest Expense | $897.0M | +44.9% |
| Income Tax | $2.23B | -31.3% |
| Net Income | $7.01B | -36.4% |
| EPS (Basic) | $15.56 | -33.4% |
| EPS (Diluted) | $15.48 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.32B | -45.8% |
| Accounts Receivable | $11.73B | +6.8% |
| Inventory | $3.75B | +14.5% |
| Current Assets | $19.94B | -9.0% |
| Total Assets | $75.50B | -1.2% |
| Current Liabilities | $15.86B | -0.2% |
| Long-term Debt | $17.88B | +7.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.03B | -35.0% |
| Investing Cash Flow | -$1.79B | -20.3% |
| Financing Cash Flow | -$8.09B | -26.7% |
| -33.5% |
| Total Liabilities |
| $43.85B |
| +3.6% |
| Stockholders' Equity | $30.58B | +3.7% |